Neuland Laboratories Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Neuland Laboratories heeft een totaal eigen vermogen van ₹14.0B en een totale schuld van ₹941.5M, wat de schuld-eigenvermogensverhouding op 6.7% brengt. De totale activa en totale passiva bedragen respectievelijk ₹19.4B en ₹5.5B. De EBIT Neuland Laboratories is ₹3.5B waardoor de rentedekking -5315.1 is. Het heeft contanten en kortetermijnbeleggingen van ₹1.9B.
Belangrijke informatie
6.7%
Verhouding schuld/eigen vermogen
₹941.46m
Schuld
| Rente dekkingsratio | -5315.1x |
| Contant | ₹1.90b |
| Aandelen | ₹13.95b |
| Totaal verplichtingen | ₹5.49b |
| Totaal activa | ₹19.44b |
Recente financiële gezondheidsupdates
Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹9.7B ) NEULANDLAB } overtreffen de korte termijn passiva ( ₹4.1B ).
Langlopende schulden: De kortetermijnactiva NEULANDLAB ( ₹9.7B ) overtreffen de langetermijnschulden ( ₹1.4B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: NEULANDLAB heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van NEULANDLAB is de afgelopen 5 jaar gedaald van 28.1% naar 6.7%.
Schuldendekking: De schuld van NEULANDLAB wordt goed gedekt door de operationele kasstroom ( 261% ).
Rentedekking: NEULANDLAB verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.